GSK names Emma Walmsley to replace Andrew Witty as CEO

GSK names Emma Walmsley to replace Andrew Witty as CEO

Wral
GlaxoSmithKline picks Emma Walmsley, a female executive of its management team, to replace CEO Andrew Witty when he retires early next year. Plus: Read her bio, watch video about the news.
view Wral